We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
Cap. Flow
-$614M
Cap. Flow %
-16.42%
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$107M
2
AAPL icon
Apple
AAPL
+$71.8M
3
TRV icon
Travelers Companies
TRV
+$27.6M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$27.4M
5
AXP icon
American Express
AXP
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Financials 10.88%
3 Technology 9.76%
4 Communication Services 9.34%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSY icon
451
Hershey
HSY
$36.5B
$482K 0.01%
5,395
NDAQ icon
452
Nasdaq
NDAQ
$52.4B
$474K 0.01%
24,450
-10,275
-30% -$196K
RHI icon
453
Robert Half
RHI
$4.01B
$474K 0.01%
10,055
+378
+4% +$19.1K
QVCGA
454
DELISTED
QVC Group Inc Series A
QVCGA
$471K 0.01%
355
+98
+38% +$128K
TRI icon
455
Thomson Reuters
TRI
$42.7B
$464K 0.01%
10,595
-1,801
-15% -$83.7K
SLF icon
456
Sun Life Financial
SLF
$45.8B
$463K 0.01%
14,894
-63,407
-81% -$2.09M
NVCN
457
DELISTED
Neovasc Inc.
NVCN
$459K 0.01%
4
+1
+33% +$115K
WMB icon
458
Williams Companies
WMB
$87.5B
$449K 0.01%
17,481
+4,245
+32% +$148K
ABUS icon
459
Arbutus Biopharma
ABUS
$879M
$445K 0.01%
100,000
-67,600
-40% -$371K
EQIX icon
460
Equinix
EQIX
$104B
$442K 0.01%
+1,460
New +$426K
CHTR icon
461
Charter Communications
CHTR
$15.7B
$441K 0.01%
+2,409
New +$446K
PTC icon
462
PTC
PTC
$14.5B
$440K 0.01%
+12,700
New +$445K
FIS icon
463
Fidelity National Information Services
FIS
$22.5B
$436K 0.01%
7,191
+1,191
+20% +$78.8K
ES icon
464
Eversource Energy
ES
$28.1B
$431K 0.01%
8,443
+1,499
+22% +$76.3K
CMG icon
465
Chipotle Mexican Grill
CMG
$42.6B
$422K 0.01%
43,950
+17,500
+66% +$214K
IQV icon
466
IQVIA
IQV
$35.4B
$418K 0.01%
+6,089
New +$416K
EIX icon
467
Edison International
EIX
$30.2B
$410K 0.01%
6,922
-6,648
-49% -$406K
JBHT icon
468
JB Hunt Transport Services
JBHT
$26.2B
$410K 0.01%
5,588
+2,592
+87% +$195K
FTR
469
DELISTED
Frontier Communications Corp.
FTR
$407K 0.01%
5,804
-622
-10% -$46.2K
CTAS icon
470
Cintas
CTAS
$84.5B
$406K 0.01%
17,840
-118,908
-87% -$2.71M
VTR icon
471
Ventas
VTR
$48.6B
$402K 0.01%
7,123
-643
-8% -$35K
SJR
472
DELISTED
Shaw Communications Inc.
SJR
$388K 0.01%
22,644
-1,000
-4% -$19.8K
ATVI
473
DELISTED
Activision Blizzard
ATVI
$388K 0.01%
+10,017
New +$361K
ANDV
474
DELISTED
Andeavor
ANDV
$387K 0.01%
+3,673
New +$396K
VAR
475
DELISTED
Varian Medical Systems, Inc.
VAR
$385K 0.01%
5,436
-4,914
-47% -$339K

Similar funds

Candriam SCA's Q4 2015 Portfolio in Review

As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.

  • Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
  • Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
  • Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
  • Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
  • Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
  • Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
  • Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.